| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| - - | HOLD | 0 @ USD 0 | USD 0 | The current share valuation price of - based on adjusted close was USD 0. The average price that - shares were previous bought at was USD 0.00279608. The current market price is -100.0% lower than average price they were purchased at. USD 0 compared to the previous valuation of however if the holding was sold on 2025-12-16 this would crystalise an overall loss. |
| 039200.KQ - Oscotec Inc. | HOLD | 0 @ KRW 36.7612 | KRW 0 | The current share valuation price of 039200.KQ based on adjusted close was KRW 36.7612. The average price that 039200.KQ shares were previous bought at was KRW 21.0043. The current market price is 75.0% higher than average price they were purchased at. The value of the holding in 039200.KQ has fallen by KRW 201,716 (USD $137) compared to the previous valuation of Oscotec Inc. |
| 182400.KQ - NKMAX LTD | HOLD | 0 @ KRW 3.8975 | KRW 0 | |
| MRUS - Merus BV | HOLD | 0 @ USD 96.92 | USD 0 | The current share valuation price of MRUS based on adjusted close was USD 96.92. The average price that MRUS shares were previous bought at was USD 56.564. The current market price is 71.3% higher than average price they were purchased at. The value of the holding in MRUS has increased by USD 7,744 compared to the previous valuation of Merus BV however if the holding was sold on 2025-12-16 this would crystalise an overall loss. |
| ARCT - Arcturus Therapeutics Holdings Inc | SELL | -124 @ USD 7.13 | USD -884 | The ETF sold 124 shares of ARCT on 2025-12-16. The shares were previously bought for an average price of USD 13.0207. The Arcturus Therapeutics Holdings Inc shares were sold for -45.2% lower than average price of previous purchases. This resulted in an overall loss of USD 730 The average price that the ETF previously sold ARCT share for is USD 13.263 which is higher than the selling price of USD 7.13 on 2025-12-16. |
| 4974.T - Takara Bio Inc. | SELL | -300 @ JPY 5.00032 | JPY -1,500 | The ETF sold 300 shares of 4974.T on 2025-12-16. The shares were previously bought for an average price of JPY 5.75157. The Takara Bio Inc. shares were sold for -13.1% lower than average price of previous purchases. This resulted in an overall loss of JPY 225 (USD $1) The average price that the ETF previously sold 4974.T share for is JPY 5.84686 which is higher than the selling price of JPY 5.00032 on 2025-12-16. |
| SLP - Sylvania Platinum Limited | SELL | -84 @ USD 18.86 | USD -1,584 | The ETF sold 84 shares of SLP on 2025-12-16. The shares were previously bought for an average price of USD 26.1345. The Sylvania Platinum Limited shares were sold for -27.8% lower than average price of previous purchases. This resulted in an overall loss of USD 611 The average price that the ETF previously sold SLP share for is USD 27.1815 which is higher than the selling price of USD 18.86 on 2025-12-16. |
| 4549.T - Eiken Chemical Co., Ltd. | SELL | -100 @ JPY 16.0669 | JPY -1,607 | The ETF sold 100 shares of 4549.T on 2025-12-16. The shares were previously bought for an average price of JPY 13.728. The Eiken Chemical Co., Ltd. shares were sold for 17.0% higher than average price of previous purchases. This sale made a profit of JPY 234 (USD $2) The average price that the ETF previously sold 4549.T share for is JPY 14.3258 so the ETF has sold 100 shares on 2025-12-16 at a higher price than the previous selling average. |
| VNDA - Vanda Pharmaceuticals Inc | SELL | -310 @ USD 6.64999 | USD -2,061 | The ETF sold 310 shares of VNDA on 2025-12-16. The shares were previously bought for an average price of USD 4.65578. The Vanda Pharmaceuticals Inc shares were sold for 42.8% higher than average price of previous purchases. This sale made a profit of USD 618 The average price that the ETF previously sold VNDA share for is USD 4.55254 so the ETF has sold 310 shares on 2025-12-16 at a higher price than the previous selling average. |
| EVH - Evolent Health Inc | SELL | -576 @ USD 4.07 | USD -2,344 | The ETF sold 576 shares of EVH on 2025-12-16. The shares were previously bought for an average price of USD 9.55347. The Evolent Health Inc shares were sold for -57.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,158 The average price that the ETF previously sold EVH share for is USD 10.8613 which is higher than the selling price of USD 4.07 on 2025-12-16. |
| 1877.HK - SHANGHAI JUNSHI BIOSCIENCES LTD H | SELL | -800 @ HKD 2.96681 | HKD -2,373 | The ETF sold 800 shares of 1877.HK on 2025-12-16. The shares were previously bought for an average price of HKD 2.51798. The SHANGHAI JUNSHI BIOSCIENCES LTD H shares were sold for 17.8% higher than average price of previous purchases. This sale made a profit of HKD 359 (USD $46) The average price that the ETF previously sold 1877.HK share for is HKD 2.00302 so the ETF has sold 800 shares on 2025-12-16 at a higher price than the previous selling average. |
| MRVI - Maravai Lifesciences Holdings Inc | SELL | -707 @ USD 3.59 | USD -2,538 | The ETF sold 707 shares of MRVI on 2025-12-16. The shares were previously bought for an average price of USD 2.97559. The Maravai Lifesciences Holdings Inc shares were sold for 20.6% higher than average price of previous purchases. This sale made a profit of USD 434 The average price that the ETF previously sold MRVI share for is USD 3.38186 so the ETF has sold 707 shares on 2025-12-16 at a higher price than the previous selling average. |
| XVIVO.ST - | SELL | -133 @ SEK 19.5196 | SEK -2,596 | The ETF sold 133 shares of XVIVO.ST on 2025-12-16. The shares were previously bought for an average price of SEK 40.1806. The shares were sold for -51.4% lower than average price of previous purchases. This resulted in an overall loss of SEK 2,748 (USD $296) The average price that the ETF previously sold XVIVO.ST share for is SEK 33.4441 which is higher than the selling price of SEK 19.5196 on 2025-12-16. |
| IBRX - Immunitybio Inc | SELL | -1,240 @ USD 2.16 | USD -2,678 | The ETF sold 1240 shares of IBRX on 2025-12-16. The shares were previously bought for an average price of USD 2.81966. The Immunitybio Inc shares were sold for -23.4% lower than average price of previous purchases. This resulted in an overall loss of USD 818 The average price that the ETF previously sold IBRX share for is USD 3.33131 which is higher than the selling price of USD 2.16 on 2025-12-16. |
| LAB - Standard Biotools Inc | SELL | -1,875 @ USD 1.49 | USD -2,794 | The ETF sold 1875 shares of LAB on 2025-12-16. The shares were previously bought for an average price of USD 1.39779. The Standard Biotools Inc shares were sold for 6.6% higher than average price of previous purchases. This sale made a profit of USD 173 The average price that the ETF previously sold LAB share for is USD 1.29383 so the ETF has sold 1875 shares on 2025-12-16 at a higher price than the previous selling average. |
| 7575.T - Japan Lifeline Co., Ltd. | SELL | -300 @ JPY 10.0459 | JPY -3,014 | The ETF sold 300 shares of 7575.T on 2025-12-16. The shares were previously bought for an average price of JPY 10.1423. The Japan Lifeline Co., Ltd. shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of JPY 29 (USD $0) The average price that the ETF previously sold 7575.T share for is JPY 9.53429 so the ETF has sold 300 shares on 2025-12-16 at a higher price than the previous selling average. |
| VLA.PA - Valneva SE | SELL | -735 @ EUR 4.19483 | EUR -3,083 | The ETF sold 735 shares of VLA.PA on 2025-12-16. The shares were previously bought for an average price of EUR 2.91512. The Valneva SE shares were sold for 43.9% higher than average price of previous purchases. This sale made a profit of EUR 941 (USD $1,106) The average price that the ETF previously sold VLA.PA share for is EUR 3.08645 so the ETF has sold 735 shares on 2025-12-16 at a higher price than the previous selling average. |
| 096530.KQ - Seegene, Inc. | SELL | -194 @ KRW 16.4173 | KRW -3,185 | The ETF sold 194 shares of 096530.KQ on 2025-12-16. The shares were previously bought for an average price of KRW 17.6933. The Seegene, Inc. shares were sold for -7.2% lower than average price of previous purchases. This resulted in an overall loss of KRW 248 (USD $0) The average price that the ETF previously sold 096530.KQ share for is KRW 20.8803 which is higher than the selling price of KRW 16.4173 on 2025-12-16. |
| PACB - Pacific Biosciences of California | SELL | -1,620 @ USD 2.02 | USD -3,272 | The ETF sold 1620 shares of PACB on 2025-12-16. The shares were previously bought for an average price of USD 1.37661. The Pacific Biosciences of California shares were sold for 46.7% higher than average price of previous purchases. This sale made a profit of USD 1,042 The average price that the ETF previously sold PACB share for is USD 1.505 so the ETF has sold 1620 shares on 2025-12-16 at a higher price than the previous selling average. |
| RO.SW - | SELL | -8 @ CHF 413.151 | CHF -3,305 | The ETF sold 8 shares of RO.SW on 2025-12-16. The shares were previously bought for an average price of CHF 370.354. The shares were sold for 11.6% higher than average price of previous purchases. This sale made a profit of CHF 342 (USD $430) The average price that the ETF previously sold RO.SW share for is CHF 331.465 so the ETF has sold 8 shares on 2025-12-16 at a higher price than the previous selling average. |
| CTKB - Cytek Biosciences Inc | SELL | -704 @ USD 4.7 | USD -3,309 | The ETF sold 704 shares of CTKB on 2025-12-16. The shares were previously bought for an average price of USD 5.7145. The Cytek Biosciences Inc shares were sold for -17.8% lower than average price of previous purchases. This resulted in an overall loss of USD 714 The average price that the ETF previously sold CTKB share for is USD 4.48201 so the ETF has sold 704 shares on 2025-12-16 at a higher price than the previous selling average. |
| IOVA - Iovance Biotherapeutics Inc | SELL | -1,492 @ USD 2.25 | USD -3,357 | The ETF sold 1492 shares of IOVA on 2025-12-16. The shares were previously bought for an average price of USD 2.41138. The Iovance Biotherapeutics Inc shares were sold for -6.7% lower than average price of previous purchases. This resulted in an overall loss of USD 241 The average price that the ETF previously sold IOVA share for is USD 4.79296 which is higher than the selling price of USD 2.25 on 2025-12-16. |
| MYGN - Myriad Genetics Inc | SELL | -488 @ USD 6.88 | USD -3,357 | The ETF sold 488 shares of MYGN on 2025-12-16. The shares were previously bought for an average price of USD 8.64702. The Myriad Genetics Inc shares were sold for -20.4% lower than average price of previous purchases. This resulted in an overall loss of USD 862 The average price that the ETF previously sold MYGN share for is USD 10.0697 which is higher than the selling price of USD 6.88 on 2025-12-16. |
| RGNX - Regenxbio Inc | SELL | -238 @ USD 14.11 | USD -3,358 | The ETF sold 238 shares of RGNX on 2025-12-16. The shares were previously bought for an average price of USD 8.67354. The Regenxbio Inc shares were sold for 62.7% higher than average price of previous purchases. This sale made a profit of USD 1,294 The average price that the ETF previously sold RGNX share for is USD 8.44705 so the ETF has sold 238 shares on 2025-12-16 at a higher price than the previous selling average. |
| DAWN - Day One Biopharmaceuticals Inc | SELL | -410 @ USD 8.25 | USD -3,383 | The ETF sold 410 shares of DAWN on 2025-12-16. The shares were previously bought for an average price of USD 8.3429. The Day One Biopharmaceuticals Inc shares were sold for -1.1% lower than average price of previous purchases. This resulted in an overall loss of USD 38 The average price that the ETF previously sold DAWN share for is USD 7.47398 so the ETF has sold 410 shares on 2025-12-16 at a higher price than the previous selling average. |
| VIR - Vir Biotechnology Inc | SELL | -543 @ USD 6.48 | USD -3,519 | The ETF sold 543 shares of VIR on 2025-12-16. The shares were previously bought for an average price of USD 7.32775. The Vir Biotechnology Inc shares were sold for -11.6% lower than average price of previous purchases. This resulted in an overall loss of USD 460 The average price that the ETF previously sold VIR share for is USD 6.48941 which is higher than the selling price of USD 6.48 on 2025-12-16. |
| VIR - Vidrala S.A | SELL | -543 @ USD 6.48 | USD -3,519 | The ETF sold 543 shares of VIR on 2025-12-16. The shares were previously bought for an average price of USD 7.32775. The Vidrala S.A shares were sold for -11.6% lower than average price of previous purchases. This resulted in an overall loss of USD 460 The average price that the ETF previously sold VIR share for is USD 6.48941 which is higher than the selling price of USD 6.48 on 2025-12-16. |
| EMBC - Embecta Corp | SELL | -308 @ USD 11.89 | USD -3,662 | The ETF sold 308 shares of EMBC on 2025-12-16. The shares were previously bought for an average price of USD 13.0183. The Embecta Corp shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 348 The average price that the ETF previously sold EMBC share for is USD 12.6358 which is higher than the selling price of USD 11.89 on 2025-12-16. |
| 328130.KQ - Lunit Inc. | SELL | -143 @ KRW 26.1661 | KRW -3,742 | The ETF sold 143 shares of 328130.KQ on 2025-12-16. The shares were previously bought for an average price of KRW 36.3011. The Lunit Inc. shares were sold for -27.9% lower than average price of previous purchases. This resulted in an overall loss of KRW 1,449 (USD $1) The average price that the ETF previously sold 328130.KQ share for is KRW 35.9518 which is higher than the selling price of KRW 26.1661 on 2025-12-16. |
| EUZ.DE - Eckert & Ziegler SE | SELL | -230 @ EUR 17.4314 | EUR -4,009 | The ETF sold 230 shares of EUZ.DE on 2025-12-16. The shares were previously bought for an average price of EUR 18.7965. The Eckert & Ziegler SE shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of EUR 314 (USD $369) The average price that the ETF previously sold EUZ.DE share for is EUR 30.402 which is higher than the selling price of EUR 17.4314 on 2025-12-16. |
| ABCL - Abcellera Biologics Inc | SELL | -1,227 @ USD 3.46 | USD -4,245 | The ETF sold 1227 shares of ABCL on 2025-12-16. The shares were previously bought for an average price of USD 3.61385. The Abcellera Biologics Inc shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of USD 189 The average price that the ETF previously sold ABCL share for is USD 2.71305 so the ETF has sold 1227 shares on 2025-12-16 at a higher price than the previous selling average. |
| 007390.KQ - NatureCell Co.,Ltd. | SELL | -280 @ KRW 15.5034 | KRW -4,341 | The ETF sold 280 shares of 007390.KQ on 2025-12-16. The shares were previously bought for an average price of KRW 21.4176. The NatureCell Co.,Ltd. shares were sold for -27.6% lower than average price of previous purchases. This resulted in an overall loss of KRW 1,656 (USD $1) The average price that the ETF previously sold 007390.KQ share for is KRW 18.5489 which is higher than the selling price of KRW 15.5034 on 2025-12-16. |
| KURA - Kura Oncology Inc | SELL | -418 @ USD 10.63 | USD -4,443 | The ETF sold 418 shares of KURA on 2025-12-16. The shares were previously bought for an average price of USD 10.711. The Kura Oncology Inc shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 34 The average price that the ETF previously sold KURA share for is USD 8.53689 so the ETF has sold 418 shares on 2025-12-16 at a higher price than the previous selling average. |
| ARVN - Arvinas Inc | SELL | -375 @ USD 11.9 | USD -4,463 | The ETF sold 375 shares of ARVN on 2025-12-16. The shares were previously bought for an average price of USD 11.3626. The Arvinas Inc shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 202 The average price that the ETF previously sold ARVN share for is USD 13.0269 which is higher than the selling price of USD 11.9 on 2025-12-16. |
| JANX - Janux Therapeutics Inc | SELL | -305 @ USD 14.65 | USD -4,468 | The ETF sold 305 shares of JANX on 2025-12-16. The shares were previously bought for an average price of USD 24.7281. The Janux Therapeutics Inc shares were sold for -40.8% lower than average price of previous purchases. This resulted in an overall loss of USD 3,074 The average price that the ETF previously sold JANX share for is USD 34.3468 which is higher than the selling price of USD 14.65 on 2025-12-16. |
| IART - Integra LifeSciences Holdings | SELL | -358 @ USD 13 | USD -4,654 | The ETF sold 358 shares of IART on 2025-12-16. The shares were previously bought for an average price of USD 20.1099. The Integra LifeSciences Holdings shares were sold for -35.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,545 The average price that the ETF previously sold IART share for is USD 18.6195 which is higher than the selling price of USD 13 on 2025-12-16. |
| ASTH - Astrana Health Inc | SELL | -214 @ USD 22.31 | USD -4,774 | The ETF sold 214 shares of ASTH on 2025-12-16. The shares were previously bought for an average price of USD 26.5685. The Astrana Health Inc shares were sold for -16.0% lower than average price of previous purchases. This resulted in an overall loss of USD 911 The average price that the ETF previously sold ASTH share for is USD 34.0673 which is higher than the selling price of USD 22.31 on 2025-12-16. |
| AMLX - Amylyx Pharmaceuticals Inc | SELL | -392 @ USD 12.31 | USD -4,826 | The ETF sold 392 shares of AMLX on 2025-12-16. The shares were previously bought for an average price of USD 13.5196. The Amylyx Pharmaceuticals Inc shares were sold for -8.9% lower than average price of previous purchases. This resulted in an overall loss of USD 474 The average price that the ETF previously sold AMLX share for is USD 10.2848 so the ETF has sold 392 shares on 2025-12-16 at a higher price than the previous selling average. |
| 302440.KS - SK BIOSCIENCE LTD | SELL | -138 @ KRW 35.2041 | KRW -4,858 | The ETF sold 138 shares of 302440.KS on 2025-12-16. The shares were previously bought for an average price of KRW 36.2275. The SK BIOSCIENCE LTD shares were sold for -2.8% lower than average price of previous purchases. This resulted in an overall loss of KRW 141 (USD $0) The average price that the ETF previously sold 302440.KS share for is KRW 31.143 so the ETF has sold 138 shares on 2025-12-16 at a higher price than the previous selling average. |
| EVT.DE - Evotec SE | SELL | -797 @ EUR 6.13217 | EUR -4,887 | The ETF sold 797 shares of EVT.DE on 2025-12-16. The shares were previously bought for an average price of EUR 6.56761. The Evotec SE shares were sold for -6.6% lower than average price of previous purchases. This resulted in an overall loss of EUR 347 (USD $408) The average price that the ETF previously sold EVT.DE share for is EUR 8.04631 which is higher than the selling price of EUR 6.13217 on 2025-12-16. |
| ONT.L - Oxford Nanopore Technologies Ltd | SELL | -3,046 @ GBP 1.68499 | GBP -5,132 | The ETF sold 3046 shares of ONT.L on 2025-12-16. The shares were previously bought for an average price of GBP 1.72772. The Oxford Nanopore Technologies Ltd shares were sold for -2.5% lower than average price of previous purchases. This resulted in an overall loss of GBP 130 (USD $174) The average price that the ETF previously sold ONT.L share for is GBP 1.61621 so the ETF has sold 3046 shares on 2025-12-16 at a higher price than the previous selling average. |
| ANAB - AnaptysBio Inc | SELL | -114 @ USD 45.03 | USD -5,133 | The ETF sold 114 shares of ANAB on 2025-12-16. The shares were previously bought for an average price of USD 23.8129. The AnaptysBio Inc shares were sold for 89.1% higher than average price of previous purchases. This sale made a profit of USD 2,419 The average price that the ETF previously sold ANAB share for is USD 21.0046 so the ETF has sold 114 shares on 2025-12-16 at a higher price than the previous selling average. |
| 2252.HK - SHANGHAI MICROPORT MEDBOT CLASS H | SELL | -2,000 @ HKD 2.59146 | HKD -5,183 | The ETF sold 2000 shares of 2252.HK on 2025-12-16. The shares were previously bought for an average price of HKD 3.16268. The SHANGHAI MICROPORT MEDBOT CLASS H shares were sold for -18.1% lower than average price of previous purchases. This resulted in an overall loss of HKD 1,142 (USD $147) The average price that the ETF previously sold 2252.HK share for is HKD 2.75605 which is higher than the selling price of HKD 2.59146 on 2025-12-16. |
| NVAX - Novavax Inc | SELL | -800 @ USD 6.54 | USD -5,232 | The ETF sold 800 shares of NVAX on 2025-12-16. The shares were previously bought for an average price of USD 6.53102. The Novavax Inc shares were sold for 0.1% higher than average price of previous purchases. This sale made a profit of USD 7 The average price that the ETF previously sold NVAX share for is USD 7.25847 which is higher than the selling price of USD 6.54 on 2025-12-16. |
| NVAX - Hana Microelectronics Public Company Limited | SELL | -800 @ USD 6.54 | USD -5,232 | The ETF sold 800 shares of NVAX on 2025-12-16. The shares were previously bought for an average price of USD 6.53102. The Hana Microelectronics Public Company Limited shares were sold for 0.1% higher than average price of previous purchases. This sale made a profit of USD 7 The average price that the ETF previously sold NVAX share for is USD 7.25847 which is higher than the selling price of USD 6.54 on 2025-12-16. |
| CDNA - Caredx Inc | SELL | -273 @ USD 19.36 | USD -5,285 | The ETF sold 273 shares of CDNA on 2025-12-16. The shares were previously bought for an average price of USD 19.212. The Caredx Inc shares were sold for 0.8% higher than average price of previous purchases. This sale made a profit of USD 40 The average price that the ETF previously sold CDNA share for is USD 19.5238 which is higher than the selling price of USD 19.36 on 2025-12-16. |
| CERT - Certara Inc | SELL | -620 @ USD 8.66 | USD -5,369 | The ETF sold 620 shares of CERT on 2025-12-16. The shares were previously bought for an average price of USD 10.4074. The Certara Inc shares were sold for -16.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,083 The average price that the ETF previously sold CERT share for is USD 10.9395 which is higher than the selling price of USD 8.66 on 2025-12-16. |
| DYVOX.ST - | SELL | -543 @ SEK 10.1205 | SEK -5,495 | The ETF sold 543 shares of DYVOX.ST on 2025-12-16. The shares were previously bought for an average price of SEK 6.29712. The shares were sold for 60.7% higher than average price of previous purchases. This sale made a profit of SEK 2,076 (USD $224) The average price that the ETF previously sold DYVOX.ST share for is SEK 7.35111 so the ETF has sold 543 shares on 2025-12-16 at a higher price than the previous selling average. |
| SDGR - Schrodinger Inc | SELL | -307 @ USD 17.94 | USD -5,508 | The ETF sold 307 shares of SDGR on 2025-12-16. The shares were previously bought for an average price of USD 22.5384. The Schrodinger Inc shares were sold for -20.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,412 The average price that the ETF previously sold SDGR share for is USD 20.9698 which is higher than the selling price of USD 17.94 on 2025-12-16. |
| 4587.T - PeptiDream Inc. | SELL | -500 @ JPY 11.0343 | JPY -5,517 | The ETF sold 500 shares of 4587.T on 2025-12-16. The shares were previously bought for an average price of JPY 11.127. The PeptiDream Inc. shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of JPY 46 (USD $0) The average price that the ETF previously sold 4587.T share for is JPY 10.7333 so the ETF has sold 500 shares on 2025-12-16 at a higher price than the previous selling average. |
| 237690.KQ - ST Pharm Co.,Ltd. | SELL | -65 @ KRW 88.755 | KRW -5,769 | The ETF sold 65 shares of 237690.KQ on 2025-12-16. The shares were previously bought for an average price of KRW 55.5458. The ST Pharm Co.,Ltd. shares were sold for 59.8% higher than average price of previous purchases. This sale made a profit of KRW 2,159 (USD $1) The average price that the ETF previously sold 237690.KQ share for is KRW 57.8949 so the ETF has sold 65 shares on 2025-12-16 at a higher price than the previous selling average. |
| CSTL - Castle Biosciences Inc | SELL | -153 @ USD 39.05 | USD -5,975 | The ETF sold 153 shares of CSTL on 2025-12-16. The shares were previously bought for an average price of USD 21.3129. The Castle Biosciences Inc shares were sold for 83.2% higher than average price of previous purchases. This sale made a profit of USD 2,714 The average price that the ETF previously sold CSTL share for is USD 23.4251 so the ETF has sold 153 shares on 2025-12-16 at a higher price than the previous selling average. |
| PHARM.AS - Pharming Group NV | SELL | -3,680 @ EUR 1.62544 | EUR -5,982 | The ETF sold 3680 shares of PHARM.AS on 2025-12-16. The shares were previously bought for an average price of EUR 0.896789. The Pharming Group NV shares were sold for 81.3% higher than average price of previous purchases. This sale made a profit of EUR 2,681 (USD $3,152) The average price that the ETF previously sold PHARM.AS share for is EUR 0.911866 so the ETF has sold 3680 shares on 2025-12-16 at a higher price than the previous selling average. |
| BLFS - BioLife Solutions Inc | SELL | -248 @ USD 24.61 | USD -6,103 | The ETF sold 248 shares of BLFS on 2025-12-16. The shares were previously bought for an average price of USD 25.7305. The BioLife Solutions Inc shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 278 The average price that the ETF previously sold BLFS share for is USD 24.4664 so the ETF has sold 248 shares on 2025-12-16 at a higher price than the previous selling average. |
| GLPG.AS - Galapagos NV | SELL | -199 @ EUR 30.8374 | EUR -6,137 | The ETF sold 199 shares of GLPG.AS on 2025-12-16. The shares were previously bought for an average price of EUR 29.0814. The Galapagos NV shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of EUR 349 (USD $411) The average price that the ETF previously sold GLPG.AS share for is EUR 26.7 so the ETF has sold 199 shares on 2025-12-16 at a higher price than the previous selling average. |
| PHM.MC - Pharma Mar SA | SELL | -71 @ EUR 86.8626 | EUR -6,167 | The ETF sold 71 shares of PHM.MC on 2025-12-16. The shares were previously bought for an average price of EUR 87.1976. The Pharma Mar SA shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of EUR 24 (USD $28) The average price that the ETF previously sold PHM.MC share for is EUR 85.2855 so the ETF has sold 71 shares on 2025-12-16 at a higher price than the previous selling average. |
| RLAY - Relay Therapeutics Inc | SELL | -745 @ USD 8.48 | USD -6,318 | The ETF sold 745 shares of RLAY on 2025-12-16. The shares were previously bought for an average price of USD 5.08308. The Relay Therapeutics Inc shares were sold for 66.8% higher than average price of previous purchases. This sale made a profit of USD 2,531 The average price that the ETF previously sold RLAY share for is USD 3.80621 so the ETF has sold 745 shares on 2025-12-16 at a higher price than the previous selling average. |
| DVAX - Dynavax Technologies Corporation | SELL | -626 @ USD 10.78 | USD -6,748 | The ETF sold 626 shares of DVAX on 2025-12-16. The shares were previously bought for an average price of USD 12.6313. The Dynavax Technologies Corporation shares were sold for -14.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,159 The average price that the ETF previously sold DVAX share for is USD 11.2198 which is higher than the selling price of USD 10.78 on 2025-12-16. |
| AXGN - Axogen Inc | SELL | -232 @ USD 29.35 | USD -6,809 | The ETF sold 232 shares of AXGN on 2025-12-16. The shares were previously bought for an average price of USD 18.047. The Axogen Inc shares were sold for 62.6% higher than average price of previous purchases. This sale made a profit of USD 2,622 The average price that the ETF previously sold AXGN share for is USD 15.1001 so the ETF has sold 232 shares on 2025-12-16 at a higher price than the previous selling average. |
| 2162.HK - KEYMED BIOSCIENCES INC | SELL | -1,000 @ HKD 6.89642 | HKD -6,896 | The ETF sold 1000 shares of 2162.HK on 2025-12-16. The shares were previously bought for an average price of HKD 5.35965. The KEYMED BIOSCIENCES INC shares were sold for 28.7% higher than average price of previous purchases. This sale made a profit of HKD 1,537 (USD $197) The average price that the ETF previously sold 2162.HK share for is HKD 5.45025 so the ETF has sold 1000 shares on 2025-12-16 at a higher price than the previous selling average. |
| ZYME - Zymeworks Inc. Common Stock | SELL | -270 @ USD 25.85 | USD -6,980 | The ETF sold 270 shares of ZYME on 2025-12-16. The shares were previously bought for an average price of USD 17.6935. The Zymeworks Inc. Common Stock shares were sold for 46.1% higher than average price of previous purchases. This sale made a profit of USD 2,202 The average price that the ETF previously sold ZYME share for is USD 12.8088 so the ETF has sold 270 shares on 2025-12-16 at a higher price than the previous selling average. |
| NVCR - Novocure Ltd | SELL | -555 @ USD 12.93 | USD -7,176 | The ETF sold 555 shares of NVCR on 2025-12-16. The shares were previously bought for an average price of USD 16.4121. The Novocure Ltd shares were sold for -21.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,933 The average price that the ETF previously sold NVCR share for is USD 17.7511 which is higher than the selling price of USD 12.93 on 2025-12-16. |
| BIOA-B.ST - | SELL | -216 @ SEK 34.2589 | SEK -7,400 | The ETF sold 216 shares of BIOA-B.ST on 2025-12-16. The shares were previously bought for an average price of SEK 29.997. The shares were sold for 14.2% higher than average price of previous purchases. This sale made a profit of SEK 921 (USD $99) The average price that the ETF previously sold BIOA-B.ST share for is SEK 19.979 so the ETF has sold 216 shares on 2025-12-16 at a higher price than the previous selling average. |
| 4887.T - Sawai Group Holdings Co., Ltd. | SELL | -500 @ JPY 15.043 | JPY -7,522 | The ETF sold 500 shares of 4887.T on 2025-12-16. The shares were previously bought for an average price of JPY 13.195. The Sawai Group Holdings Co., Ltd. shares were sold for 14.0% higher than average price of previous purchases. This sale made a profit of JPY 924 (USD $6) The average price that the ETF previously sold 4887.T share for is JPY 12.8314 so the ETF has sold 500 shares on 2025-12-16 at a higher price than the previous selling average. |
| FTRE - Fortrea Holdings Inc. | SELL | -488 @ USD 15.99 | USD -7,803 | The ETF sold 488 shares of FTRE on 2025-12-16. The shares were previously bought for an average price of USD 10.5322. The Fortrea Holdings Inc. shares were sold for 51.8% higher than average price of previous purchases. This sale made a profit of USD 2,663 The average price that the ETF previously sold FTRE share for is USD 10.7054 so the ETF has sold 488 shares on 2025-12-16 at a higher price than the previous selling average. |
| 13.HK - HUTCHMED (CHINA) LTD | SELL | -3,000 @ HKD 2.60946 | HKD -7,828 | The ETF sold 3000 shares of 13.HK on 2025-12-16. The shares were previously bought for an average price of HKD 3.01399. The HUTCHMED (CHINA) LTD shares were sold for -13.4% lower than average price of previous purchases. This resulted in an overall loss of HKD 1,214 (USD $156) The average price that the ETF previously sold 13.HK share for is HKD 3.09688 which is higher than the selling price of HKD 2.60946 on 2025-12-16. |
| NEOG - Neogen Corporation | SELL | -1,135 @ USD 7.04 | USD -7,990 | The ETF sold 1135 shares of NEOG on 2025-12-16. The shares were previously bought for an average price of USD 9.99438. The Neogen Corporation shares were sold for -29.6% lower than average price of previous purchases. This resulted in an overall loss of USD 3,353 The average price that the ETF previously sold NEOG share for is USD 9.12495 which is higher than the selling price of USD 7.04 on 2025-12-16. |
| TNDM - Tandem Diabetes Care Inc | SELL | -362 @ USD 22.6 | USD -8,181 | The ETF sold 362 shares of TNDM on 2025-12-16. The shares were previously bought for an average price of USD 21.1386. The Tandem Diabetes Care Inc shares were sold for 6.9% higher than average price of previous purchases. This sale made a profit of USD 529 The average price that the ETF previously sold TNDM share for is USD 23.1806 which is higher than the selling price of USD 22.6 on 2025-12-16. |
| BCRX - BioCryst Pharmaceuticals Inc | SELL | -1,132 @ USD 7.47 | USD -8,456 | The ETF sold 1132 shares of BCRX on 2025-12-16. The shares were previously bought for an average price of USD 7.74854. The BioCryst Pharmaceuticals Inc shares were sold for -3.6% lower than average price of previous purchases. This resulted in an overall loss of USD 315 The average price that the ETF previously sold BCRX share for is USD 7.93666 which is higher than the selling price of USD 7.47 on 2025-12-16. |
| RCUS - Arcus Biosciences Inc | SELL | -387 @ USD 22.2 | USD -8,591 | The ETF sold 387 shares of RCUS on 2025-12-16. The shares were previously bought for an average price of USD 9.14068. The Arcus Biosciences Inc shares were sold for 142.9% higher than average price of previous purchases. This sale made a profit of USD 5,054 The average price that the ETF previously sold RCUS share for is USD 11.7875 so the ETF has sold 387 shares on 2025-12-16 at a higher price than the previous selling average. |
| RXRX - Recursion Pharmaceuticals Inc | SELL | -2,072 @ USD 4.2 | USD -8,702 | The ETF sold 2072 shares of RXRX on 2025-12-16. The shares were previously bought for an average price of USD 5.14428. The Recursion Pharmaceuticals Inc shares were sold for -18.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,957 The average price that the ETF previously sold RXRX share for is USD 5.62858 which is higher than the selling price of USD 4.2 on 2025-12-16. |
| NEU.AX - | SELL | -688 @ AUD 12.947 | AUD -8,908 | The ETF sold 688 shares of NEU.AX on 2025-12-16. The shares were previously bought for an average price of AUD 8.87049. The shares were sold for 46.0% higher than average price of previous purchases. This sale made a profit of AUD 2,805 (USD $1,863) The average price that the ETF previously sold NEU.AX share for is AUD 8.29627 so the ETF has sold 688 shares on 2025-12-16 at a higher price than the previous selling average. |
| HRMY - Harmony Biosciences Holdings | SELL | -231 @ USD 38.83 | USD -8,970 | The ETF sold 231 shares of HRMY on 2025-12-16. The shares were previously bought for an average price of USD 32.6637. The Harmony Biosciences Holdings shares were sold for 18.9% higher than average price of previous purchases. This sale made a profit of USD 1,424 The average price that the ETF previously sold HRMY share for is USD 32.3601 so the ETF has sold 231 shares on 2025-12-16 at a higher price than the previous selling average. |
| TXG - 10X Genomics Inc | SELL | -576 @ USD 15.71 | USD -9,049 | The ETF sold 576 shares of TXG on 2025-12-16. The shares were previously bought for an average price of USD 12.5355. The 10X Genomics Inc shares were sold for 25.3% higher than average price of previous purchases. This sale made a profit of USD 1,829 The average price that the ETF previously sold TXG share for is USD 11.2676 so the ETF has sold 576 shares on 2025-12-16 at a higher price than the previous selling average. |
| TXG - Terex Corporation | SELL | -576 @ USD 15.71 | USD -9,049 | The ETF sold 576 shares of TXG on 2025-12-16. The shares were previously bought for an average price of USD 12.5355. The Terex Corporation shares were sold for 25.3% higher than average price of previous purchases. This sale made a profit of USD 1,829 The average price that the ETF previously sold TXG share for is USD 11.2676 so the ETF has sold 576 shares on 2025-12-16 at a higher price than the previous selling average. |
| TWST - Twist Bioscience Corp | SELL | -297 @ USD 31.13 | USD -9,246 | The ETF sold 297 shares of TWST on 2025-12-16. The shares were previously bought for an average price of USD 36.2456. The Twist Bioscience Corp shares were sold for -14.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,519 The average price that the ETF previously sold TWST share for is USD 38.4434 which is higher than the selling price of USD 31.13 on 2025-12-16. |
| 6951.T - JEOL Ltd. | SELL | -300 @ JPY 31.0614 | JPY -9,318 | The ETF sold 300 shares of 6951.T on 2025-12-16. The shares were previously bought for an average price of JPY 33.0489. The JEOL Ltd. shares were sold for -6.0% lower than average price of previous purchases. This resulted in an overall loss of JPY 596 (USD $4) The average price that the ETF previously sold 6951.T share for is JPY 32.4507 which is higher than the selling price of JPY 31.0614 on 2025-12-16. |
| 3933.HK - THE UNITED LABORATORIES INTERNATIO | SELL | -6,000 @ HKD 1.55925 | HKD -9,356 | The ETF sold 6000 shares of 3933.HK on 2025-12-16. The shares were previously bought for an average price of HKD 1.67688. The THE UNITED LABORATORIES INTERNATIO shares were sold for -7.0% lower than average price of previous purchases. This resulted in an overall loss of HKD 706 (USD $91) The average price that the ETF previously sold 3933.HK share for is HKD 1.6035 which is higher than the selling price of HKD 1.55925 on 2025-12-16. |
| KNSA - Kiniksa Pharmaceuticals Ltd | SELL | -228 @ USD 41.37 | USD -9,432 | The ETF sold 228 shares of KNSA on 2025-12-16. The shares were previously bought for an average price of USD 40.3374. The Kiniksa Pharmaceuticals Ltd shares were sold for 2.6% higher than average price of previous purchases. This sale made a profit of USD 235 The average price that the ETF previously sold KNSA share for is USD 34.854 so the ETF has sold 228 shares on 2025-12-16 at a higher price than the previous selling average. |
| STOK - Stoke Therapeutics Inc | SELL | -283 @ USD 33.61 | USD -9,512 | The ETF sold 283 shares of STOK on 2025-12-16. The shares were previously bought for an average price of USD 12.0607. The Stoke Therapeutics Inc shares were sold for 178.7% higher than average price of previous purchases. This sale made a profit of USD 6,098 The average price that the ETF previously sold STOK share for is USD 12.2671 so the ETF has sold 283 shares on 2025-12-16 at a higher price than the previous selling average. |
| HLUN-B.CO - | SELL | -1,420 @ DKK 6.7897 | DKK -9,641 | The ETF sold 1420 shares of HLUN-B.CO on 2025-12-16. The shares were previously bought for an average price of DKK 6.0023. The shares were sold for 13.1% higher than average price of previous purchases. This sale made a profit of DKK 1,118 (USD $176) The average price that the ETF previously sold HLUN-B.CO share for is DKK 5.19214 so the ETF has sold 1420 shares on 2025-12-16 at a higher price than the previous selling average. |
| CHEMM.CO - | SELL | -92 @ DKK 105.705 | DKK -9,725 | The ETF sold 92 shares of CHEMM.CO on 2025-12-16. The shares were previously bought for an average price of DKK 78.2284. The shares were sold for 35.1% higher than average price of previous purchases. This sale made a profit of DKK 2,528 (USD $398) The average price that the ETF previously sold CHEMM.CO share for is DKK 74.7047 so the ETF has sold 92 shares on 2025-12-16 at a higher price than the previous selling average. |
| 9995.HK - REMEGEN LTD H | SELL | -1,000 @ HKD 9.80796 | HKD -9,808 | The ETF sold 1000 shares of 9995.HK on 2025-12-16. The shares were previously bought for an average price of HKD 9.70899. The REMEGEN LTD H shares were sold for 1.0% higher than average price of previous purchases. This sale made a profit of HKD 99 (USD $13) The average price that the ETF previously sold 9995.HK share for is HKD 4.10233 so the ETF has sold 1000 shares on 2025-12-16 at a higher price than the previous selling average. |
| DIA.MI - DiaSorin SpA | SELL | -136 @ EUR 74.2687 | EUR -10,101 | The ETF sold 136 shares of DIA.MI on 2025-12-16. The shares were previously bought for an average price of EUR 54.1257. The DiaSorin SpA shares were sold for 37.2% higher than average price of previous purchases. This sale made a profit of EUR 2,739 (USD $3,220) The average price that the ETF previously sold DIA.MI share for is EUR 108.132 which is higher than the selling price of EUR 74.2687 on 2025-12-16. |
| QDEL - Quidel Corporation | SELL | -350 @ USD 28.88 | USD -10,108 | The ETF sold 350 shares of QDEL on 2025-12-16. The shares were previously bought for an average price of USD 29.52. The Quidel Corporation shares were sold for -2.2% lower than average price of previous purchases. This resulted in an overall loss of USD 224 The average price that the ETF previously sold QDEL share for is USD 32.7277 which is higher than the selling price of USD 28.88 on 2025-12-16. |
| TECN.SW - | SELL | -67 @ CHF 157.164 | CHF -10,530 | The ETF sold 67 shares of TECN.SW on 2025-12-16. The shares were previously bought for an average price of CHF 197.12. The shares were sold for -20.3% lower than average price of previous purchases. This resulted in an overall loss of CHF 2,677 (USD $3,363) The average price that the ETF previously sold TECN.SW share for is CHF 207.308 which is higher than the selling price of CHF 157.164 on 2025-12-16. |
| ATRC - AtriCure Inc | SELL | -259 @ USD 41.08 | USD -10,640 | The ETF sold 259 shares of ATRC on 2025-12-16. The shares were previously bought for an average price of USD 33.402. The AtriCure Inc shares were sold for 23.0% higher than average price of previous purchases. This sale made a profit of USD 1,989 The average price that the ETF previously sold ATRC share for is USD 33.5547 so the ETF has sold 259 shares on 2025-12-16 at a higher price than the previous selling average. |
| CRVL - CorVel Corp | SELL | -155 @ USD 70.54 | USD -10,934 | The ETF sold 155 shares of CRVL on 2025-12-16. The shares were previously bought for an average price of USD 111.522. The CorVel Corp shares were sold for -36.7% lower than average price of previous purchases. This resulted in an overall loss of USD 6,352 The average price that the ETF previously sold CRVL share for is USD 137.909 which is higher than the selling price of USD 70.54 on 2025-12-16. |
| BANB.SW - | SELL | -164 @ CHF 67.0145 | CHF -10,990 | The ETF sold 164 shares of BANB.SW on 2025-12-16. The shares were previously bought for an average price of CHF 65.0923. The shares were sold for 3.0% higher than average price of previous purchases. This sale made a profit of CHF 315 (USD $396) The average price that the ETF previously sold BANB.SW share for is CHF 67.397 which is higher than the selling price of CHF 67.0145 on 2025-12-16. |
| AUPH - Aurinia Pharmaceuticals Inc | SELL | -697 @ USD 15.85 | USD -11,047 | The ETF sold 697 shares of AUPH on 2025-12-16. The shares were previously bought for an average price of USD 11.2153. The Aurinia Pharmaceuticals Inc shares were sold for 41.3% higher than average price of previous purchases. This sale made a profit of USD 3,230 The average price that the ETF previously sold AUPH share for is USD 8.3928 so the ETF has sold 697 shares on 2025-12-16 at a higher price than the previous selling average. |
| NUVB - Nuvation Bio Inc | SELL | -1,279 @ USD 8.66 | USD -11,076 | The ETF sold 1279 shares of NUVB on 2025-12-16. The shares were previously bought for an average price of USD 6.64051. The Nuvation Bio Inc shares were sold for 30.4% higher than average price of previous purchases. This sale made a profit of USD 2,583 The average price that the ETF previously sold NUVB share for is USD 3.66207 so the ETF has sold 1279 shares on 2025-12-16 at a higher price than the previous selling average. |
| SRPT - Sarepta Therapeutics Inc | SELL | -527 @ USD 22.31 | USD -11,757 | The ETF sold 527 shares of SRPT on 2025-12-16. The shares were previously bought for an average price of USD 45.0034. The Sarepta Therapeutics Inc shares were sold for -50.4% lower than average price of previous purchases. This resulted in an overall loss of USD 11,959 The average price that the ETF previously sold SRPT share for is USD 68.7251 which is higher than the selling price of USD 22.31 on 2025-12-16. |
| EKTA-B.ST - | SELL | -1,955 @ SEK 6.06152 | SEK -11,850 | The ETF sold 1955 shares of EKTA-B.ST on 2025-12-16. The shares were previously bought for an average price of SEK 5.63298. The shares were sold for 7.6% higher than average price of previous purchases. This sale made a profit of SEK 838 (USD $90) The average price that the ETF previously sold EKTA-B.ST share for is SEK 5.08738 so the ETF has sold 1955 shares on 2025-12-16 at a higher price than the previous selling average. |
| BAVA.CO - | SELL | -414 @ DKK 28.9074 | DKK -11,968 | The ETF sold 414 shares of BAVA.CO on 2025-12-16. The shares were previously bought for an average price of DKK 25.4205. The shares were sold for 13.7% higher than average price of previous purchases. This sale made a profit of DKK 1,444 (USD $227) The average price that the ETF previously sold BAVA.CO share for is DKK 25.8197 so the ETF has sold 414 shares on 2025-12-16 at a higher price than the previous selling average. |
| CGON - CG Oncology, Inc. Common stock | SELL | -325 @ USD 37.85 | USD -12,301 | The ETF sold 325 shares of CGON on 2025-12-16. The shares were previously bought for an average price of USD 41.6925. The CG Oncology, Inc. Common stock shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,249 The average price that the ETF previously sold CGON share for is USD 35.2966 so the ETF has sold 325 shares on 2025-12-16 at a higher price than the previous selling average. |
| ADPT - Adaptive Biotechnologies Corp | SELL | -798 @ USD 15.93 | USD -12,712 | The ETF sold 798 shares of ADPT on 2025-12-16. The shares were previously bought for an average price of USD 6.89362. The Adaptive Biotechnologies Corp shares were sold for 131.1% higher than average price of previous purchases. This sale made a profit of USD 7,211 The average price that the ETF previously sold ADPT share for is USD 8.16317 so the ETF has sold 798 shares on 2025-12-16 at a higher price than the previous selling average. |
| 326030.KS - SK BIOPHARMACEUTICALS LTD | SELL | -147 @ KRW 89.4997 | KRW -13,156 | The ETF sold 147 shares of 326030.KS on 2025-12-16. The shares were previously bought for an average price of KRW 77.4592. The SK BIOPHARMACEUTICALS LTD shares were sold for 15.5% higher than average price of previous purchases. This sale made a profit of KRW 1,770 (USD $1) The average price that the ETF previously sold 326030.KS share for is KRW 72.418 so the ETF has sold 147 shares on 2025-12-16 at a higher price than the previous selling average. |
| SUPN - Supernus Pharmaceuticals Inc | SELL | -292 @ USD 48.32 | USD -14,109 | The ETF sold 292 shares of SUPN on 2025-12-16. The shares were previously bought for an average price of USD 36.2354. The Supernus Pharmaceuticals Inc shares were sold for 33.4% higher than average price of previous purchases. This sale made a profit of USD 3,529 The average price that the ETF previously sold SUPN share for is USD 34.4744 so the ETF has sold 292 shares on 2025-12-16 at a higher price than the previous selling average. |
| BEAM - Beam Therapeutics Inc | SELL | -535 @ USD 26.76 | USD -14,317 | The ETF sold 535 shares of BEAM on 2025-12-16. The shares were previously bought for an average price of USD 18.6816. The Beam Therapeutics Inc shares were sold for 43.2% higher than average price of previous purchases. This sale made a profit of USD 4,322 The average price that the ETF previously sold BEAM share for is USD 20.9232 so the ETF has sold 535 shares on 2025-12-16 at a higher price than the previous selling average. |
| VRDN - Viridian Therapeutics Inc | SELL | -437 @ USD 32.85 | USD -14,355 | The ETF sold 437 shares of VRDN on 2025-12-16. The shares were previously bought for an average price of USD 30.1226. The Viridian Therapeutics Inc shares were sold for 9.1% higher than average price of previous purchases. This sale made a profit of USD 1,192 The average price that the ETF previously sold VRDN share for is USD 21.1146 so the ETF has sold 437 shares on 2025-12-16 at a higher price than the previous selling average. |
| ACLX - Arcellx Inc | SELL | -220 @ USD 66.33 | USD -14,593 | The ETF sold 220 shares of ACLX on 2025-12-16. The shares were previously bought for an average price of USD 64.8725. The Arcellx Inc shares were sold for 2.2% higher than average price of previous purchases. This sale made a profit of USD 321 The average price that the ETF previously sold ACLX share for is USD 72.4919 which is higher than the selling price of USD 66.33 on 2025-12-16. |
| CPRX - Catalyst Pharmaceuticals Inc | SELL | -646 @ USD 24.19 | USD -15,627 | The ETF sold 646 shares of CPRX on 2025-12-16. The shares were previously bought for an average price of USD 22.4325. The Catalyst Pharmaceuticals Inc shares were sold for 7.8% higher than average price of previous purchases. This sale made a profit of USD 1,135 The average price that the ETF previously sold CPRX share for is USD 22.3586 so the ETF has sold 646 shares on 2025-12-16 at a higher price than the previous selling average. |
| IDYA - Ideaya Biosciences Inc | SELL | -463 @ USD 33.81 | USD -15,654 | The ETF sold 463 shares of IDYA on 2025-12-16. The shares were previously bought for an average price of USD 23.8167. The Ideaya Biosciences Inc shares were sold for 42.0% higher than average price of previous purchases. This sale made a profit of USD 4,627 The average price that the ETF previously sold IDYA share for is USD 21.92 so the ETF has sold 463 shares on 2025-12-16 at a higher price than the previous selling average. |
| VCYT - Veracyte Inc | SELL | -385 @ USD 43.22 | USD -16,640 | The ETF sold 385 shares of VCYT on 2025-12-16. The shares were previously bought for an average price of USD 34.3612. The Veracyte Inc shares were sold for 25.8% higher than average price of previous purchases. This sale made a profit of USD 3,411 The average price that the ETF previously sold VCYT share for is USD 33.8083 so the ETF has sold 385 shares on 2025-12-16 at a higher price than the previous selling average. |
| ACAD - ACADIA Pharmaceuticals Inc | SELL | -652 @ USD 26.8 | USD -17,474 | The ETF sold 652 shares of ACAD on 2025-12-16. The shares were previously bought for an average price of USD 20.1364. The ACADIA Pharmaceuticals Inc shares were sold for 33.1% higher than average price of previous purchases. This sale made a profit of USD 4,345 The average price that the ETF previously sold ACAD share for is USD 17.3355 so the ETF has sold 652 shares on 2025-12-16 at a higher price than the previous selling average. |
| LIVN - LivaNova PLC | SELL | -281 @ USD 63.08 | USD -17,725 | The ETF sold 281 shares of LIVN on 2025-12-16. The shares were previously bought for an average price of USD 46.485. The LivaNova PLC shares were sold for 35.7% higher than average price of previous purchases. This sale made a profit of USD 4,663 The average price that the ETF previously sold LIVN share for is USD 44.758 so the ETF has sold 281 shares on 2025-12-16 at a higher price than the previous selling average. |
| SFZN.SW - | SELL | -209 @ CHF 90.4005 | CHF -18,894 | The ETF sold 209 shares of SFZN.SW on 2025-12-16. The shares were previously bought for an average price of CHF 123.569. The shares were sold for -26.8% lower than average price of previous purchases. This resulted in an overall loss of CHF 6,932 (USD $8,709) The average price that the ETF previously sold SFZN.SW share for is CHF 296.924 which is higher than the selling price of CHF 90.4005 on 2025-12-16. |
| LGND - Ligand Pharmaceuticals Incorporated | SELL | -101 @ USD 192.63 | USD -19,456 | The ETF sold 101 shares of LGND on 2025-12-16. The shares were previously bought for an average price of USD 126.392. The Ligand Pharmaceuticals Incorporated shares were sold for 52.4% higher than average price of previous purchases. This sale made a profit of USD 6,690 The average price that the ETF previously sold LGND share for is USD 117.624 so the ETF has sold 101 shares on 2025-12-16 at a higher price than the previous selling average. |
| SECT-B.ST - | SELL | -769 @ SEK 27.3468 | SEK -21,030 | The ETF sold 769 shares of SECT-B.ST on 2025-12-16. The shares were previously bought for an average price of SEK 28.0136. The shares were sold for -2.4% lower than average price of previous purchases. This resulted in an overall loss of SEK 513 (USD $55) The average price that the ETF previously sold SECT-B.ST share for is SEK 28.8844 which is higher than the selling price of SEK 27.3468 on 2025-12-16. |
| TGTX - TG Therapeutics Inc | SELL | -751 @ USD 30.79 | USD -23,123 | The ETF sold 751 shares of TGTX on 2025-12-16. The shares were previously bought for an average price of USD 33.8235. The TG Therapeutics Inc shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,278 The average price that the ETF previously sold TGTX share for is USD 34.3192 which is higher than the selling price of USD 30.79 on 2025-12-16. |
| 298380.KQ - ABL Bio Inc. | SELL | -182 @ KRW 128.901 | KRW -23,460 | The ETF sold 182 shares of 298380.KQ on 2025-12-16. The shares were previously bought for an average price of KRW 40.1877. The ABL Bio Inc. shares were sold for 220.7% higher than average price of previous purchases. This sale made a profit of KRW 16,146 (USD $11) The average price that the ETF previously sold 298380.KQ share for is KRW 37.2617 so the ETF has sold 182 shares on 2025-12-16 at a higher price than the previous selling average. |
| LNTH - Lantheus Holdings Inc | SELL | -363 @ USD 65.17 | USD -23,657 | The ETF sold 363 shares of LNTH on 2025-12-16. The shares were previously bought for an average price of USD 76.9588. The Lantheus Holdings Inc shares were sold for -15.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,279 The average price that the ETF previously sold LNTH share for is USD 87.6201 which is higher than the selling price of USD 65.17 on 2025-12-16. |
| ALKS - Alkermes Plc | SELL | -862 @ USD 28.06 | USD -24,188 | The ETF sold 862 shares of ALKS on 2025-12-16. The shares were previously bought for an average price of USD 30.7179. The Alkermes Plc shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,291 The average price that the ETF previously sold ALKS share for is USD 29.4935 which is higher than the selling price of USD 28.06 on 2025-12-16. |
| 7747.T - Asahi Intecc Co., Ltd. | SELL | -1,300 @ JPY 19.2551 | JPY -25,032 | The ETF sold 1300 shares of 7747.T on 2025-12-16. The shares were previously bought for an average price of JPY 16.8906. The Asahi Intecc Co., Ltd. shares were sold for 14.0% higher than average price of previous purchases. This sale made a profit of JPY 3,074 (USD $20) The average price that the ETF previously sold 7747.T share for is JPY 15.9078 so the ETF has sold 1300 shares on 2025-12-16 at a higher price than the previous selling average. |
| MMS - LYXETFETUSITETFP | SELL | -294 @ USD 87.77 | USD -25,804 | The ETF sold 294 shares of MMS on 2025-12-16. The shares were previously bought for an average price of USD 75.2803. The LYXETFETUSITETFP shares were sold for 16.6% higher than average price of previous purchases. This sale made a profit of USD 3,672 The average price that the ETF previously sold MMS share for is USD 71.9649 so the ETF has sold 294 shares on 2025-12-16 at a higher price than the previous selling average. |
| 6869.T - Sysmex Corporation | SELL | -2,700 @ JPY 9.85206 | JPY -26,601 | The ETF sold 2700 shares of 6869.T on 2025-12-16. The shares were previously bought for an average price of JPY 14.9756. The Sysmex Corporation shares were sold for -34.2% lower than average price of previous purchases. This resulted in an overall loss of JPY 13,834 (USD $89) The average price that the ETF previously sold 6869.T share for is JPY 17.9896 which is higher than the selling price of JPY 9.85206 on 2025-12-16. |
| IPN.PA - Ipsen SA | SELL | -189 @ EUR 141.946 | EUR -26,828 | The ETF sold 189 shares of IPN.PA on 2025-12-16. The shares were previously bought for an average price of EUR 120.641. The Ipsen SA shares were sold for 17.7% higher than average price of previous purchases. This sale made a profit of EUR 4,027 (USD $4,733) The average price that the ETF previously sold IPN.PA share for is EUR 116.925 so the ETF has sold 189 shares on 2025-12-16 at a higher price than the previous selling average. |
| PRAX - Praxis Precision Medicines Inc | SELL | -107 @ USD 274.51 | USD -29,373 | The ETF sold 107 shares of PRAX on 2025-12-16. The shares were previously bought for an average price of USD 167.342. The Praxis Precision Medicines Inc shares were sold for 64.0% higher than average price of previous purchases. This sale made a profit of USD 11,467 The average price that the ETF previously sold PRAX share for is USD 121.905 so the ETF has sold 107 shares on 2025-12-16 at a higher price than the previous selling average. |
| AXSM - Axsome Therapeutics Inc | SELL | -200 @ USD 146.87 | USD -29,374 | The ETF sold 200 shares of AXSM on 2025-12-16. The shares were previously bought for an average price of USD 116.831. The Axsome Therapeutics Inc shares were sold for 25.7% higher than average price of previous purchases. This sale made a profit of USD 6,008 The average price that the ETF previously sold AXSM share for is USD 105.658 so the ETF has sold 200 shares on 2025-12-16 at a higher price than the previous selling average. |
| PTCT - PTC Therapeutics Inc | SELL | -412 @ USD 75.42 | USD -31,073 | The ETF sold 412 shares of PTCT on 2025-12-16. The shares were previously bought for an average price of USD 56.4444. The PTC Therapeutics Inc shares were sold for 33.6% higher than average price of previous purchases. This sale made a profit of USD 7,818 The average price that the ETF previously sold PTCT share for is USD 48.147 so the ETF has sold 412 shares on 2025-12-16 at a higher price than the previous selling average. |
| BIM.PA - BioMerieux | SELL | -254 @ EUR 126.174 | EUR -32,048 | The ETF sold 254 shares of BIM.PA on 2025-12-16. The shares were previously bought for an average price of EUR 121.406. The BioMerieux shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of EUR 1,211 (USD $1,424) The average price that the ETF previously sold BIM.PA share for is EUR 122.983 so the ETF has sold 254 shares on 2025-12-16 at a higher price than the previous selling average. |
| BIO - Bio-Rad Laboratories Inc | SELL | -111 @ USD 302.02 | USD -33,524 | The ETF sold 111 shares of BIO on 2025-12-16. The shares were previously bought for an average price of USD 290.296. The Bio-Rad Laboratories Inc shares were sold for 4.0% higher than average price of previous purchases. This sale made a profit of USD 1,301 The average price that the ETF previously sold BIO share for is USD 268.231 so the ETF has sold 111 shares on 2025-12-16 at a higher price than the previous selling average. |
| BIO - Biotest Aktiengesellschaft | SELL | -111 @ USD 302.02 | USD -33,524 | The ETF sold 111 shares of BIO on 2025-12-16. The shares were previously bought for an average price of USD 290.296. The Biotest Aktiengesellschaft shares were sold for 4.0% higher than average price of previous purchases. This sale made a profit of USD 1,301 The average price that the ETF previously sold BIO share for is USD 268.231 so the ETF has sold 111 shares on 2025-12-16 at a higher price than the previous selling average. |
| RYTM - Rhythm Pharmaceuticals Inc | SELL | -302 @ USD 112.45 | USD -33,960 | The ETF sold 302 shares of RYTM on 2025-12-16. The shares were previously bought for an average price of USD 67.8137. The Rhythm Pharmaceuticals Inc shares were sold for 65.8% higher than average price of previous purchases. This sale made a profit of USD 13,480 The average price that the ETF previously sold RYTM share for is USD 62.7519 so the ETF has sold 302 shares on 2025-12-16 at a higher price than the previous selling average. |
| SRT3.DE - Sartorius AG | SELL | -132 @ EUR 282.715 | EUR -37,318 | The ETF sold 132 shares of SRT3.DE on 2025-12-16. The shares were previously bought for an average price of EUR 247.576. The Sartorius AG shares were sold for 14.2% higher than average price of previous purchases. This sale made a profit of EUR 4,638 (USD $5,452) The average price that the ETF previously sold SRT3.DE share for is EUR 239.842 so the ETF has sold 132 shares on 2025-12-16 at a higher price than the previous selling average. |
| HALO - Halozyme Therapeutics Inc | SELL | -644 @ USD 64.47 | USD -41,519 | The ETF sold 644 shares of HALO on 2025-12-16. The shares were previously bought for an average price of USD 60.3305. The Halozyme Therapeutics Inc shares were sold for 6.9% higher than average price of previous purchases. This sale made a profit of USD 2,666 The average price that the ETF previously sold HALO share for is USD 54.7026 so the ETF has sold 644 shares on 2025-12-16 at a higher price than the previous selling average. |
| 7701.T - Shimadzu Corporation | SELL | -1,500 @ JPY 27.8377 | JPY -41,757 | The ETF sold 1500 shares of 7701.T on 2025-12-16. The shares were previously bought for an average price of JPY 26.4723. The Shimadzu Corporation shares were sold for 5.2% higher than average price of previous purchases. This sale made a profit of JPY 2,048 (USD $13) The average price that the ETF previously sold 7701.T share for is JPY 26.0522 so the ETF has sold 1500 shares on 2025-12-16 at a higher price than the previous selling average. |
| RGEN - Repligen Corporation | SELL | -274 @ USD 158.09 | USD -43,317 | The ETF sold 274 shares of RGEN on 2025-12-16. The shares were previously bought for an average price of USD 145.299. The Repligen Corporation shares were sold for 8.8% higher than average price of previous purchases. This sale made a profit of USD 3,505 The average price that the ETF previously sold RGEN share for is USD 134.73 so the ETF has sold 274 shares on 2025-12-16 at a higher price than the previous selling average. |
| PME.AX - | SELL | -293 @ AUD 150.086 | AUD -43,975 | The ETF sold 293 shares of PME.AX on 2025-12-16. The shares were previously bought for an average price of AUD 165.183. The shares were sold for -9.1% lower than average price of previous purchases. This resulted in an overall loss of AUD 4,423 (USD $2,938) The average price that the ETF previously sold PME.AX share for is AUD 150.22 which is higher than the selling price of AUD 150.086 on 2025-12-16. |
| 4523.T - Eisai Co., Ltd. | SELL | -1,500 @ JPY 29.8469 | JPY -44,770 | The ETF sold 1500 shares of 4523.T on 2025-12-16. The shares were previously bought for an average price of JPY 28.5269. The Eisai Co., Ltd. shares were sold for 4.6% higher than average price of previous purchases. This sale made a profit of JPY 1,980 (USD $13) The average price that the ETF previously sold 4523.T share for is JPY 28.5458 so the ETF has sold 1500 shares on 2025-12-16 at a higher price than the previous selling average. |
| TECH - Bio-Techne Corp | SELL | -819 @ USD 57.44 | USD -47,043 | The ETF sold 819 shares of TECH on 2025-12-16. The shares were previously bought for an average price of USD 59.3169. The Bio-Techne Corp shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,537 The average price that the ETF previously sold TECH share for is USD 59.0189 which is higher than the selling price of USD 57.44 on 2025-12-16. |
| CRL - Creightons Plc | SELL | -256 @ USD 195.22 | USD -49,976 | The ETF sold 256 shares of CRL on 2025-12-16. The shares were previously bought for an average price of USD 165.907. The Creightons Plc shares were sold for 17.7% higher than average price of previous purchases. This sale made a profit of USD 7,504 The average price that the ETF previously sold CRL share for is USD 154.108 so the ETF has sold 256 shares on 2025-12-16 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -757 @ USD 66.37 | USD -50,242 | The ETF sold 757 shares of DXCM on 2025-12-16. The shares were previously bought for an average price of USD 78.8148. The DexCom Inc shares were sold for -15.8% lower than average price of previous purchases. This resulted in an overall loss of USD 9,421 The average price that the ETF previously sold DXCM share for is USD 74.3491 which is higher than the selling price of USD 66.37 on 2025-12-16. |
| QIA.DE - QIAGEN NV | SELL | -1,132 @ EUR 44.7142 | EUR -50,616 | The ETF sold 1132 shares of QIA.DE on 2025-12-16. The shares were previously bought for an average price of EUR 43.4373. The QIAGEN NV shares were sold for 2.9% higher than average price of previous purchases. This sale made a profit of EUR 1,445 (USD $1,699) The average price that the ETF previously sold QIA.DE share for is EUR 43.1073 so the ETF has sold 1132 shares on 2025-12-16 at a higher price than the previous selling average. |
| RVTY - Revvity Inc. | SELL | -615 @ USD 96.27 | USD -59,206 | The ETF sold 615 shares of RVTY on 2025-12-16. The shares were previously bought for an average price of USD 100.003. The Revvity Inc. shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,296 The average price that the ETF previously sold RVTY share for is USD 96.7044 which is higher than the selling price of USD 96.27 on 2025-12-16. |
| EXEL - Exelixis Inc | SELL | -1,424 @ USD 41.6 | USD -59,238 | The ETF sold 1424 shares of EXEL on 2025-12-16. The shares were previously bought for an average price of USD 38.1215. The Exelixis Inc shares were sold for 9.1% higher than average price of previous purchases. This sale made a profit of USD 4,953 The average price that the ETF previously sold EXEL share for is USD 38.7402 so the ETF has sold 1424 shares on 2025-12-16 at a higher price than the previous selling average. |
| LONN.SW - | SELL | -91 @ CHF 652.543 | CHF -59,381 | The ETF sold 91 shares of LONN.SW on 2025-12-16. The shares were previously bought for an average price of CHF 640.611. The shares were sold for 1.9% higher than average price of previous purchases. This sale made a profit of CHF 1,086 (USD $1,364) The average price that the ETF previously sold LONN.SW share for is CHF 663.553 which is higher than the selling price of CHF 652.543 on 2025-12-16. |
| BSX - Boston Scientific Corporation | SELL | -646 @ USD 92.95 | USD -60,046 | The ETF sold 646 shares of BSX on 2025-12-16. The shares were previously bought for an average price of USD 97.6281. The Boston Scientific Corporation shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 3,022 The average price that the ETF previously sold BSX share for is USD 98.7581 which is higher than the selling price of USD 92.95 on 2025-12-16. |
| BSX - MULSTRXSSXIMETFP | SELL | -646 @ USD 92.95 | USD -60,046 | The ETF sold 646 shares of BSX on 2025-12-16. The shares were previously bought for an average price of USD 97.6281. The MULSTRXSSXIMETFP shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 3,022 The average price that the ETF previously sold BSX share for is USD 98.7581 which is higher than the selling price of USD 92.95 on 2025-12-16. |
| MRNA - Moderna Inc | SELL | -2,020 @ USD 29.89 | USD -60,378 | The ETF sold 2020 shares of MRNA on 2025-12-16. The shares were previously bought for an average price of USD 25.9653. The Moderna Inc shares were sold for 15.1% higher than average price of previous purchases. This sale made a profit of USD 7,928 The average price that the ETF previously sold MRNA share for is USD 30.2757 which is higher than the selling price of USD 29.89 on 2025-12-16. |
| ABT - Abbott Laboratories | SELL | -479 @ USD 126.86 | USD -60,766 | The ETF sold 479 shares of ABT on 2025-12-16. The shares were previously bought for an average price of USD 124.674. The Abbott Laboratories shares were sold for 1.8% higher than average price of previous purchases. This sale made a profit of USD 1,047 The average price that the ETF previously sold ABT share for is USD 128.986 which is higher than the selling price of USD 126.86 on 2025-12-16. |
| PODD - Insulet Corporation | SELL | -215 @ USD 288.73 | USD -62,077 | The ETF sold 215 shares of PODD on 2025-12-16. The shares were previously bought for an average price of USD 282.956. The Insulet Corporation shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of USD 1,241 The average price that the ETF previously sold PODD share for is USD 292.815 which is higher than the selling price of USD 288.73 on 2025-12-16. |
| GH - Guardant Health Inc | SELL | -647 @ USD 100 | USD -64,700 | The ETF sold 647 shares of GH on 2025-12-16. The shares were previously bought for an average price of USD 54.9629. The Guardant Health Inc shares were sold for 81.9% higher than average price of previous purchases. This sale made a profit of USD 29,139 The average price that the ETF previously sold GH share for is USD 42.9401 so the ETF has sold 647 shares on 2025-12-16 at a higher price than the previous selling average. |
| 207940.KS - SAMSUNG BIOLOGICS LTD | SELL | -55 @ KRW 1211.83 | KRW -66,651 | The ETF sold 55 shares of 207940.KS on 2025-12-16. The shares were previously bought for an average price of KRW 760.081. The SAMSUNG BIOLOGICS LTD shares were sold for 59.4% higher than average price of previous purchases. This sale made a profit of KRW 24,846 (USD $17) The average price that the ETF previously sold 207940.KS share for is KRW 960.357 so the ETF has sold 55 shares on 2025-12-16 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -121 @ USD 554.58 | USD -67,104 | The ETF sold 121 shares of ISRG on 2025-12-16. The shares were previously bought for an average price of USD 536.021. The Intuitive Surgical Inc shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of USD 2,246 The average price that the ETF previously sold ISRG share for is USD 517.921 so the ETF has sold 121 shares on 2025-12-16 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -2,643 @ USD 25.53 | USD -67,476 | The ETF sold 2643 shares of PFE on 2025-12-16. The shares were previously bought for an average price of USD 24.3485. The Pfizer Inc shares were sold for 4.9% higher than average price of previous purchases. This sale made a profit of USD 3,123 The average price that the ETF previously sold PFE share for is USD 24.3401 so the ETF has sold 2643 shares on 2025-12-16 at a higher price than the previous selling average. |
| 068270.KS - CELLTRION INC | SELL | -540 @ KRW 125.652 | KRW -67,852 | The ETF sold 540 shares of 068270.KS on 2025-12-16. The shares were previously bought for an average price of KRW 121.694. The CELLTRION INC shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of KRW 2,137 (USD $1) The average price that the ETF previously sold 068270.KS share for is KRW 119.722 so the ETF has sold 540 shares on 2025-12-16 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -583 @ USD 118.78 | USD -69,249 | The ETF sold 583 shares of GILD on 2025-12-16. The shares were previously bought for an average price of USD 107.342. The Guild Esports Plc shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 6,668 The average price that the ETF previously sold GILD share for is USD 106.097 so the ETF has sold 583 shares on 2025-12-16 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,285 @ USD 54.23 | USD -69,686 | The ETF sold 1285 shares of BMY on 2025-12-16. The shares were previously bought for an average price of USD 53.3317. The Bloomsbury Publishing Plc shares were sold for 1.7% higher than average price of previous purchases. This sale made a profit of USD 1,154 The average price that the ETF previously sold BMY share for is USD 50.6095 so the ETF has sold 1285 shares on 2025-12-16 at a higher price than the previous selling average. |
| MEDP - Medpace Holdings Inc | SELL | -125 @ USD 558.74 | USD -69,843 | The ETF sold 125 shares of MEDP on 2025-12-16. The shares were previously bought for an average price of USD 382.527. The Medpace Holdings Inc shares were sold for 46.1% higher than average price of previous purchases. This sale made a profit of USD 22,027 The average price that the ETF previously sold MEDP share for is USD 336.497 so the ETF has sold 125 shares on 2025-12-16 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -317 @ USD 224.7 | USD -71,230 | The ETF sold 317 shares of DHR on 2025-12-16. The shares were previously bought for an average price of USD 199.979. The Danaher Corporation shares were sold for 12.4% higher than average price of previous purchases. This sale made a profit of USD 7,837 The average price that the ETF previously sold DHR share for is USD 209.741 so the ETF has sold 317 shares on 2025-12-16 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -317 @ USD 224.7 | USD -71,230 | The ETF sold 317 shares of DHR on 2025-12-16. The shares were previously bought for an average price of USD 199.979. The Danaher Corporation shares were sold for 12.4% higher than average price of previous purchases. This sale made a profit of USD 7,837 The average price that the ETF previously sold DHR share for is USD 209.741 so the ETF has sold 317 shares on 2025-12-16 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -730 @ USD 97.72 | USD -71,336 | The ETF sold 730 shares of MDT on 2025-12-16. The shares were previously bought for an average price of USD 90.2193. The Medtronic PLC shares were sold for 8.3% higher than average price of previous purchases. This sale made a profit of USD 5,476 The average price that the ETF previously sold MDT share for is USD 86.6761 so the ETF has sold 730 shares on 2025-12-16 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -219 @ USD 326.74 | USD -71,556 | The ETF sold 219 shares of AMGN on 2025-12-16. The shares were previously bought for an average price of USD 296.507. The Amgen Inc shares were sold for 10.2% higher than average price of previous purchases. This sale made a profit of USD 6,621 The average price that the ETF previously sold AMGN share for is USD 290.642 so the ETF has sold 219 shares on 2025-12-16 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -847 @ USD 85.32 | USD -72,266 | The ETF sold 847 shares of EW on 2025-12-16. The shares were previously bought for an average price of USD 74.591. The Edwards Lifesciences Corp shares were sold for 14.4% higher than average price of previous purchases. This sale made a profit of USD 9,087 The average price that the ETF previously sold EW share for is USD 72.6565 so the ETF has sold 847 shares on 2025-12-16 at a higher price than the previous selling average. |
| NOVN.SW - | SELL | -541 @ CHF 135.135 | CHF -73,108 | The ETF sold 541 shares of NOVN.SW on 2025-12-16. The shares were previously bought for an average price of CHF 113.545. The shares were sold for 19.0% higher than average price of previous purchases. This sale made a profit of CHF 11,680 (USD $14,674) The average price that the ETF previously sold NOVN.SW share for is CHF 111.467 so the ETF has sold 541 shares on 2025-12-16 at a higher price than the previous selling average. |
| HOLX - Hologic Inc | SELL | -986 @ USD 75.02 | USD -73,970 | The ETF sold 986 shares of HOLX on 2025-12-16. The shares were previously bought for an average price of USD 66.2934. The Hologic Inc shares were sold for 13.2% higher than average price of previous purchases. This sale made a profit of USD 8,604 The average price that the ETF previously sold HOLX share for is USD 66.4723 so the ETF has sold 986 shares on 2025-12-16 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -532 @ USD 139.19 | USD -74,049 | The ETF sold 532 shares of A on 2025-12-16. The shares were previously bought for an average price of USD 122.269. The Agilent Technologies Inc shares were sold for 13.8% higher than average price of previous purchases. This sale made a profit of USD 9,002 The average price that the ETF previously sold A share for is USD 121.765 so the ETF has sold 532 shares on 2025-12-16 at a higher price than the previous selling average. |
| ROG.SW - | SELL | -187 @ CHF 402.842 | CHF -75,331 | The ETF sold 187 shares of ROG.SW on 2025-12-16. The shares were previously bought for an average price of CHF 324.411. The shares were sold for 24.2% higher than average price of previous purchases. This sale made a profit of CHF 14,667 (USD $18,425) The average price that the ETF previously sold ROG.SW share for is CHF 313.44 so the ETF has sold 187 shares on 2025-12-16 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -338 @ USD 223.67 | USD -75,600 | The ETF sold 338 shares of ABBV on 2025-12-16. The shares were previously bought for an average price of USD 201.245. The AbbVie Inc shares were sold for 11.1% higher than average price of previous purchases. This sale made a profit of USD 7,580 The average price that the ETF previously sold ABBV share for is USD 187.011 so the ETF has sold 338 shares on 2025-12-16 at a higher price than the previous selling average. |
| NBIX - Neurocrine Biosciences Inc | SELL | -514 @ USD 148.74 | USD -76,452 | The ETF sold 514 shares of NBIX on 2025-12-16. The shares were previously bought for an average price of USD 127.74. The Neurocrine Biosciences Inc shares were sold for 16.4% higher than average price of previous purchases. This sale made a profit of USD 10,794 The average price that the ETF previously sold NBIX share for is USD 115.882 so the ETF has sold 514 shares on 2025-12-16 at a higher price than the previous selling average. |
| GSK.L - GlaxoSmithKline PLC | SELL | -3,151 @ GBP 24.4095 | GBP -76,914 | The ETF sold 3151 shares of GSK.L on 2025-12-16. The shares were previously bought for an average price of GBP 19.3589. The GlaxoSmithKline PLC shares were sold for 26.1% higher than average price of previous purchases. This sale made a profit of GBP 15,914 (USD $21,295) The average price that the ETF previously sold GSK.L share for is GBP 18.3156 so the ETF has sold 3151 shares on 2025-12-16 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -789 @ USD 98.27 | USD -77,535 | The ETF sold 789 shares of MRK on 2025-12-16. The shares were previously bought for an average price of USD 80.8147. The Marks Electrical Group PLC shares were sold for 21.6% higher than average price of previous purchases. This sale made a profit of USD 13,772 The average price that the ETF previously sold MRK share for is USD 87.9013 so the ETF has sold 789 shares on 2025-12-16 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -789 @ USD 98.27 | USD -77,535 | The ETF sold 789 shares of MRK on 2025-12-16. The shares were previously bought for an average price of USD 80.8147. The Merck & Company Inc shares were sold for 21.6% higher than average price of previous purchases. This sale made a profit of USD 13,772 The average price that the ETF previously sold MRK share for is USD 87.9013 so the ETF has sold 789 shares on 2025-12-16 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -473 @ USD 171.5 | USD -81,120 | The ETF sold 473 shares of BIIB on 2025-12-16. The shares were previously bought for an average price of USD 130.477. The Biogen Inc shares were sold for 31.4% higher than average price of previous purchases. This sale made a profit of USD 19,404 The average price that the ETF previously sold BIIB share for is USD 140.163 so the ETF has sold 473 shares on 2025-12-16 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -410 @ USD 209.3 | USD -85,813 | The ETF sold 410 shares of JNJ on 2025-12-16. The shares were previously bought for an average price of USD 170.984. The Johnson & Johnson shares were sold for 22.4% higher than average price of previous purchases. This sale made a profit of USD 15,710 The average price that the ETF previously sold JNJ share for is USD 156.918 so the ETF has sold 410 shares on 2025-12-16 at a higher price than the previous selling average. |
| GMAB.CO - | SELL | -280 @ DKK 312.941 | DKK -87,623 | The ETF sold 280 shares of GMAB.CO on 2025-12-16. The shares were previously bought for an average price of DKK 222.447. The shares were sold for 40.7% higher than average price of previous purchases. This sale made a profit of DKK 25,338 (USD $3,988) The average price that the ETF previously sold GMAB.CO share for is DKK 214.174 so the ETF has sold 280 shares on 2025-12-16 at a higher price than the previous selling average. |
| NTRA - Natera Inc | SELL | -388 @ USD 227.4 | USD -88,231 | The ETF sold 388 shares of NTRA on 2025-12-16. The shares were previously bought for an average price of USD 176.324. The Natera Inc shares were sold for 29.0% higher than average price of previous purchases. This sale made a profit of USD 19,817 The average price that the ETF previously sold NTRA share for is USD 164.611 so the ETF has sold 388 shares on 2025-12-16 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -155 @ USD 570.16 | USD -88,375 | The ETF sold 155 shares of TMO on 2025-12-16. The shares were previously bought for an average price of USD 418.499. The Time Out Group plc shares were sold for 36.2% higher than average price of previous purchases. This sale made a profit of USD 23,507 The average price that the ETF previously sold TMO share for is USD 482.821 so the ETF has sold 155 shares on 2025-12-16 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -401 @ USD 221.68 | USD -88,894 | The ETF sold 401 shares of IQV on 2025-12-16. The shares were previously bought for an average price of USD 162.435. The IQVIA Holdings Inc shares were sold for 36.5% higher than average price of previous purchases. This sale made a profit of USD 23,757 The average price that the ETF previously sold IQV share for is USD 176.919 so the ETF has sold 401 shares on 2025-12-16 at a higher price than the previous selling average. |
| UCB.BR - UCB SA | SELL | -341 @ EUR 279.538 | EUR -95,322 | The ETF sold 341 shares of UCB.BR on 2025-12-16. The shares were previously bought for an average price of EUR 208.203. The UCB SA shares were sold for 34.3% higher than average price of previous purchases. This sale made a profit of EUR 24,325 (USD $28,593) The average price that the ETF previously sold UCB.BR share for is EUR 182.957 so the ETF has sold 341 shares on 2025-12-16 at a higher price than the previous selling average. |
| ILMN - Illumina Inc | SELL | -729 @ USD 131.56 | USD -95,907 | The ETF sold 729 shares of ILMN on 2025-12-16. The shares were previously bought for an average price of USD 95.299. The Illumina Inc shares were sold for 38.0% higher than average price of previous purchases. This sale made a profit of USD 26,434 The average price that the ETF previously sold ILMN share for is USD 101.36 so the ETF has sold 729 shares on 2025-12-16 at a higher price than the previous selling average. |
| EXAS - EXACT Sciences Corporation | SELL | -984 @ USD 101.76 | USD -100,132 | The ETF sold 984 shares of EXAS on 2025-12-16. The shares were previously bought for an average price of USD 62.0439. The EXACT Sciences Corporation shares were sold for 64.0% higher than average price of previous purchases. This sale made a profit of USD 39,081 The average price that the ETF previously sold EXAS share for is USD 52.5665 so the ETF has sold 984 shares on 2025-12-16 at a higher price than the previous selling average. |